Enocitabine

Enocitabine

Systematic (IUPAC) name
N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	IV
Legal status	℞ (Prescription only)
Identifiers
CAS Number	55726-47-1
ATC code	none
PubChem	CID 71734
ChemSpider	64778
UNII	9YVR68W306
KEGG	D01633
ChEMBL	CHEMBL2106589
Chemical data
Formula	C31H55N3O6
Molar mass	565.78 g/mol
SMILES O=C(N/C/1=N/C(=O)N(\C=C\1)[C@@H]2O[C@@H]([C@@H](O)[C@@H]2O)CO)CCCCCCCCCCCCCCCCCCCCC
InChI InChI=1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 Key:SAMRUMKYXPVKPA-VFKOLLTISA-N
(what is this?)  (verify)

Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.

Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.^[1]

References

1. Tatetsu H, Asou N, Nakamura M; et al. (July 2003). "[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]". Rinsho Ketsueki (in Japanese) 44 (7): 471–3. PMID 12931567.

• (Japanese) Sunrabin